TITUSVILLE, N.J., July 10, 2012 /PRNewswire/ -- Janssen Research & Development, LLC, ("Janssen") announced today that it has committed $5.4 million in a new research sponsorship to advance the formation of a first-of-its-kind networked initiative aimed at uncovering the genetic and biologic causes of multiple sclerosis (MS) and accelerating new treatments for the disease. The sponsorship expands Janssen's Healthy Minds initiative, a program launched in 2011 to accelerate progress in the fight against neurologic and brain disorders and to build on the company's longstanding commitment to neuroscience and mental health.
Under the research sponsorship, the Marin Community Foundation's (MCF) Multiple Sclerosis Project Fund will create an alliance of public and private research collaborators and enable data sharing and integration of scientific research using advanced computer-based systems modeling tools and analytics. The alliance will work together to expand and refine knowledge of MS and advance the creation of new approaches to treating disease with the aim of accelerating the identification of new targets, biomarkers and approaches to treatment.
"The commitment of new funds under our Healthy Minds program to this research effort in MS builds on the longstanding Janssen tradition of advancing neuroscience research and commitment to innovative collaboration," said Husseini K. Manji, M.D., Global Therapeutic Area Head for Neuroscience, Janssen Research & Development, LLC. "Our aim is to bring together researchers and data to foster the development of new, transformational medicines and treatment paradigms to solve mysteries of the brain and central nervous system."
MS is a chronic neurological disorder affecting more than 350,000 people in the United States and 2.5 million worldwide. MS attacks the central nervous system by destroying myelin, the layer of insulation protecting nerve fibers and axons in the brain.
|SOURCE Janssen Research & Development, LLC|
Copyright©2012 PR Newswire.
All rights reserved